Search company, investor...

Cornerstone Therapeutics

crtx.com

Stage

Acquired | Acquired

Total Raised

$56.15M

About Cornerstone Therapeutics

Cornerstone Therapeutics (NASDAQ: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Key elements of Cornerstone's strategy are to focus its commercial and development efforts in the hospital and adjacent specialty product sector within the U.S. pharmaceutical marketplace; continue to seek out opportunities to acquire companies, marketed or registration-stage products and late-stage development products that fit within Cornerstone's focus areas; and generate revenues by marketing approved generic products through Cornerstone's wholly-owned subsidiary, Aristos Pharmaceuticals.

Headquarters Location

1255 Crescent Green Drive Suite 250

Cary, North Carolina, 27518,

United States

919-678-6611

Missing: Cornerstone Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cornerstone Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Cornerstone Therapeutics Patents

Cornerstone Therapeutics has filed 8 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/29/2014

8/30/2016

Ion channels, Cannabinoids, Nicotinic acetylcholine receptors, Designer drugs, Nicotinic antagonists

Grant

Application Date

7/29/2014

Grant Date

8/30/2016

Title

Related Topics

Ion channels, Cannabinoids, Nicotinic acetylcholine receptors, Designer drugs, Nicotinic antagonists

Status

Grant

Latest Cornerstone Therapeutics News

Cornerstone Therapeutics Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Dec 3, 2016

Cornerstone Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 16:26 EST 3 Dec 2016 | BioPortfolio Reports Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » Cornerstone Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cornerstone Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Cornerstone Therapeutics, Inc. since January 2007. Key Findings Provides intelligence on Cornerstone Therapeutics, Inc.'s MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Cornerstone Therapeutics, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Cornerstone Therapeutics, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Cornerstone Therapeutics, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Cornerstone Therapeutics Frequently Asked Questions (FAQ)

  • Where is Cornerstone Therapeutics's headquarters?

    Cornerstone Therapeutics's headquarters is located at 1255 Crescent Green Drive, Cary.

  • What is Cornerstone Therapeutics's latest funding round?

    Cornerstone Therapeutics's latest funding round is Acquired.

  • How much did Cornerstone Therapeutics raise?

    Cornerstone Therapeutics raised a total of $56.15M.

  • Who are the investors of Cornerstone Therapeutics?

    Investors of Cornerstone Therapeutics include Chiesi Farmaceutici, Johnson & Johnson Innovation, Oxford Bioscience Partners, MPM Capital, Advanced Technology Ventures and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.